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3-Hydroxy-3-methyl-glutaryl-CoA reductase (HMGR) is a key enzyme in the sterol biosynthesis pathway, but its
subcellular distribution in the Trypanosomatidae family is somewhat controversial. Trypanosoma cruzi and Leishmania
HMGRs are closely related in their catalytic domains to bacterial and eukaryotic enzymes described but lack an
amino-terminal domain responsible for the attachment to the endoplasmic reticulum. In the present study, digitonin-
titration experiments together with immunoelectron microscopy were used to establish the intracellular localization of
HMGR in these pathogens. Results obtained with wild-type cells and transfectants overexpressing the enzyme estab-
lished that HMGR in both T. cruzi and Leishmania major is localized primarily in the mitochondrion and that elimination
of the mitochondrial targeting sequence in Leishmania leads to protein accumulation in the cytosolic compartment.
Furthermore, T. cruzi HMGR is efficiently targeted to the mitochondrion in yeast cells. Thus, when the gene encoding T.
cruzi HMGR was expressed in a hmg1 hmg2 mutant of Saccharomyces cerevisiae, the mevalonate auxotrophy of mutant
cells was relieved, and immunoelectron analysis showed that the parasite enzyme exhibits a mitochondrial localization,
suggesting a conservation between the targeting signals of both organisms.
INTRODUCTION
Trypanosoma cruzi and Leishmania species are the etiological
agents of Chagas’ disease and leishmaniases, respectively,
and both exhibit complex life cycles. After invasion of mam-
malian cells, parasites differentiate into intracellular amasti-
gotes, which multiply and are able to infect new cells or gain
access to a new vector (De Souza, 1984). Despite consider-
able work, neither a vaccine to prevent these diseases nor
satisfactory drugs are available. Current treatments are ei-
ther expensive, have severe side effects, or are ineffective in
many cases (Croft et al., 1997). Several promising target
molecules for the treatment of this disease are enzymes
involved in isoprenoid metabolism also called the meval-
onate pathway (Urbina, 1997). The mevalonate pathway
provides precursors for the diverse spectrum of isoprenoid
compounds (Sacchettini and Poulter, 1997; Edwards and
Ericsson, 1999), some of which have been shown to be es-
sential for the growth and development of eukaryotic cells
(Rao, 1995). The pathway starts with the synthesis of meva-
lonate catalyzed by 3-hydroxy-3-methyl-glutaryl-CoA re-
ductase (HMGR), a key enzyme that is subject to several
regulatory mechanisms (Goldstein and Brown, 1990;
Stermer et al., 1994; Hampton et al., 1996). Potent HMGR
inhibitors with Ki values in the nanomolar range are avail-
able (Endo and Hasumi, 1992). In trypanosomatids, the im-
portance of isoprenoids for cell viability and proliferation
has been proved, and the combination of inhibitors that act
at different points of the pathway seems to be a useful
strategy against T. cruzi and Leishmania infections (Gebre-
Hiwot and Frommel, 1993; Maldonado et al., 1993; Urbina,
1997).
Although eukaryotic HMGR enzymes are very conserved
in sequence and subcellular distribution, they differ in size,
membrane topology, quaternary structure, and mechanisms
of regulation. HMGR and the mevalonate pathway have
been studied in detail in eukaryotes, yet the information
available regarding this enzyme in trypanosomatids is lim-
ited. Thus, the localization of the enzyme remains obscure
and controversial; HMGR from Trypanosoma brucei was re-
ported to be microsomal (Coppens et al., 1995) and mito-
chondrial (Heise and Opperdoes, 2000), whereas the T. cruzi
enzyme was found to be glycosomal (Concepcio´n et al.,
1998).
We have previously isolated the gene encoding HMGR
from T. cruzi and Leishmania major and demonstrated that
they lack the membrane N-terminal domain characteristic of
eukaryotic HMGRs and responsible for the attachment to
endoplasmic reticulum (ER), thus determining a soluble
form of the enzyme (Pen˜a-Dı´az et al., 1997; Montalvetti et al.,
2000). Comparison of several trypanosomatid mitochondrial
proteins revealed that T. cruzi (Tc)HMGR and Leishmania
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(Lm)HMGR exhibit a short, putative mitochondrial signal.
All evidence so far indicates that the mechanism of mito-
chondrial protein import is conserved among eukaryotes.
Nuclear-encoded mitochondrial matrix proteins from
trypanosomatids have cleaved N-terminal peptides. Se-
quence comparisons suggested that two groups of mito-
chondrial targeting signals could function in trypanosomes.
One group consists of sequences 15–20 amino acids in length
that are similar to signals known in yeast and other organ-
isms. The other group of sequences is exceptionally short
(7–9 amino acids) and also function in yeast albeit rather
inefficiently (Ha¨usler et al., 1997).
In an effort to resolve the controversy regarding cellular
localization of HMGR in the Trypanosomatidae, permeabi-
lization analysis, and immunoelectron microscopy have
been used to study in detail the subcellular distribution of
the enzyme, showing it to be mitochondrial and that amino
terminal sequences are responsible for targeting of the en-
zyme to the mitochondrial matrix. Furthermore, expression
of TcHMGR in the yeast double mutant hmg1 hmg2 allows
cells to grow in the absence of mevalonate, and TcHMGR
was efficiently targeted to the mitochondrion, hence show-
ing conserved import mechanisms among both organisms
(Basson et al., 1987).
MATERIALS AND METHODS
Materials
Restriction enzymes, T4 DNA ligase, Taq polymerase, aprotinin, leupeptin,
reverse transcriptase M-MuLV, and the RNase inhibitor were from Roche
Diagnostics (Mannheim, Germany). [-32P]ATP was from ICN Pharmaceuti-
cals (Irvine, CA). d,l-[3-14C]3-hydroxy-3-methylglutaryl-CoA was from Am-
ersham Biosciences (Piscataway, NJ), and R,S-[5-3H(N)]mevalonolactone was
from DuPont (Wilmington, DE). Benzamidine, bovine serum albumin (BSA),
dithiothreitol, d,l-3-hydroxy-3-methylglutaryl-CoA, d,l-mevalonic acid lac-
tone, 1,10-phenanthroline, phenylmethylsulfonyl fluoride, trypsin inhibitor,
sodium phosphate, and mevalonic acid were from Sigma-Aldrich (St. Louis,
MO). The mRNA purification kit was from Pharmacia (Peapack, NJ). Oligo-
nucleotides CLC1 and CLC2 were hybrid constructions that anneal with the
5 and 3region, respectively, of S. cerevisiae HMG2 (uppercase) and a part of
kanMX4 from Ashbya gossypii (lowercase) and were purchased from ISOGEN.
The sequences were as follows: CLC1 (5-TGAAGAGCCAAAGATAC-
CAACTGAATAGTGTCTGAAAACGGAACcgtacg ctgcaggtcgacg-3) and
CLC2 (5-TCTTTGGTTAAAACAGTTGTTGCACCACCACCAGC ATTGAT-
GGCTatcgatgaattcgagctcgtt-3). Other oligonucleotides were synthesized at
Analytical Services (Instituto deParasitologı´a y Biomedicina “Lo´pez Neyra”,
Granada, Spain). BamHI-ATG (5-CGCGGATCCCCATGTTTCG-
TAGGGCAATTCT-3) and HindIII-TGA (5-CGCTAAGCTTTCACTTCTTCT-
TGCGATTCAG-3) were designed to amplify the coding region of the
TcHMGR gene, Neo-ATG (5-CTCGAAGCTTATGGGATCGGCCATTGAACA-
3) and Neo-TGA (5-CTGGAATTCAGCGGGGAAAAAACAAAAAACACGC-
3) were used to amplify the coding region of the aminoglycoside phosphotrans-
ferase gene (NEO), and 5rDNA (5-GATATTTGCGCACCCACCTT-3) and
3rDNA (5-GCGACAGACAATTCACGCAC-3) were used for amplifying an
rDNA region. For overexpression of truncated forms of LmHMGR, the oligonu-
cleotides LmHMGR1i (5-GGAATTGGATCCATGGAGAGCTGGGCATCC-3),
LmHMGR2i (5-GGAATTGGATCCATGTCCGATACAGAG-3), and LmHMGR3f
(5-ATCGCAAGCTTTTACGGAGTCGGAGGC-3) were used.
Strains and Culture Methods
The epimastigote form of T. cruzi Y was cultured in filter-sterilized LIT
medium with 10% (vol/vol) heat-inactivated fetal calf serum (Invitrogen,
Carlsbad, CA) in tissue culture flasks at 28°C. Leishmania major 252 wild-type
cells were grown in M199 medium with 10% (vol/vol) heat-inactivated fetal
calf serum under the same conditions as T. cruzi cells.
Yeast strains were grown at 30°C in rich medium containing 2% glucose
(YPD) and minimal medium containing 2% glucose. Amino acids and meva-
lonate supplements were added, when needed, at the following concentra-
tions: 20 g/ml adenine, histidine, and tryptophan; 30 g/ml leucine; and 20
mM mevalonate. Solid medium contained 2% agar.
Overexpression of HMGR in T. cruzi Y Cells
The vector pRIBOTEX was kindly provided by Roberto Hernandez (Mar-
tı´nez-Calvillo et al., 19973). Insertion of the coding sequence for TcHMGR
flanked by the restriction sites BamHI and HindIII into the polylinker of
pRIBOTEX created the expression vector pRIBOTEX1-HMGR. The oligonu-
cleotides for the amplification of the insert were the sense BamHI-ATG and
the antisense HindIII-TGA. Conditions for electroporation of the cells were
those reported by Martı´nez-Calvillo et al., 1997. A control of transfection by
using void pRIBOTEX was run in parallel. Poly (A) RNA was obtained and
the splice acceptor site was assessed by reverse transcription-polymerase
chain (PCR) reaction and sequencing as described previously (Pen˜a-Dı´az et
al., 1997).
Overexpression of HMGR in Leishmania major Cells
The coding region of L. major HMGR was cloned in the BamHI site of the
vector pSP72NEO (Papadopoulou et al., 1994) to generate pSP72hmgr.
Truncated versions of the LMHMGR gene were amplified by PCR and cloned
in the BamHI and HindIII sites of pSP72neo to give pSP72hmgr1 and
pSP72hmgr2, which lack the first 42 and 57 base pairs, respectively, of the
LMHMGR gene. Conditions of transfection and selection of positive clones
were as reported previously (Papadopoulou et al., 1994).
Contour-clamped Homogeneous Electric Field (CHEF)
Electrophoresis
Low-melting-point agarose blocks were prepared as described previously
(Garvey and Santi, 1986; Ellenberg and Beverley, 1989). Chromosomes were
separated on a 1% agarose gel in 0.5 M Tris borate-EDTA by using a CHEF
electrophoresis system (Pharmacia). The parameters used were frequencies of
75 s for 28 h, frequencies of 100 s for 18 h, frequencies of 200 s for 18 h, and
frequencies of 250 s for 0 h at 120 V. Molecular masses of the chromosomal
DNA bands were determined by comparison with DNA standards from S.
cerevisiae strain YNN295 (Bio-Rad, Hercules, CA). The resulting gel was
transferred to a Hybond-N nylon filter (Amersham Biosciences) and subjected
to Southern blot analysis by using as probes the TcHMGR and LMHMGR
genes, NEO gene, and an rDNA fragment.
Yeast Strain Construction
Plasmid pAN10HMGTc carrying TcHMGR under the control of the ADH1
promoter of S. cerevisiae was constructed as follows: an NdeI-BamHI segment
containing the complete TcHMGR coding sequence was obtained from pETH-
MGR. HindIII linkers were added, and the resulting fragment was cloned in
the HindIII site of pAN10 (Navas et al., 1993). The plasmid carrying the
TcHMGR gene in the adequate orientation was termed pAN10HMGTc.
All strains used in this study were derived from W303 (ade2 try1 leu2 his3
ura3). Two yeast strains with disruptions in HMG1 and HMG2, respectively,
were constructed as follows. Plasmid pJR429 (Basson et al., 1986) was digested
with SphI, and the 2.9-kb fragment containing HMG1 was inserted in the SphI
site of pUC18. The resulting construct was digested with BglII that eliminates
a 1.8-kb fragment internal to the HMG1 gene. This fragment was replaced by
a 1.76-kb fragment from plasmid YDpH carrying the HIS3 gene (Berben et al.,
1991). The 2.86-kb SphI-SphI fragment of this construct was used to disrupt the
chromosomal copy from S. cerevisiae. Correct integration was verified by
Southern blot analysis.
HMG2 was disrupted with the gene kanMX4 from A. gossypii that confers
resistance to geneticine (Wach et al., 1994). Oligonucleotides CLC1 and CLC2
hybridize, respectively, with regions 5 and 3 of HMG2 and kanMX4. A PCR
reaction was performed with these oligonucleotides by using plasmid
pFA6akanMX4 as template (Wach et al., 1994), and the product of the reaction
was used to disrupt the chromosomal copy of HMG2 in S. cerevisiae. Southern
blot analysis of the transformants showed that the integration occurred at the
correct place. To obtain the double hmg1 hmg2 mutant, the strains bearing the
hmg1 and hmg2 disruptions were crossed and the diploid sporulated. Sporu-
lation was poor, and the spores that ought to have carried the hmg1::HIS3
hmg2::KanMX4 interruptions did not germinate well even in media supple-
mented with mevalonate. Therefore, the diploid hmg1 and hmg2 was trans-
formed with pAN10HMGTc and sporulated. All spores germinated and those
bearing the double interruption were identified by the disruption markers.
Results of plasmid loss experiments showed the gene of T. cruzi complements
the lack of the yeast HMGR genes. A tetratype was selected among the tetrads
and after plasmid loss, a spore with the double disruption (strain CFL9) was
retained.
Measurement of HMG-CoA Reductase Activity
The activity of the enzyme was determined by a radiometric assay as de-
scribed previously (Pen˜a-Dı´az et al., 1997). Yeast cells were grown to mid-log
phase (15  106 cells/ml), harvested, and disrupted using glass beads (Daum
et al., 1982). Supernatants obtained after centrifugation at 1500  g were used
for determining enzyme activity. Strains W303 and CFL9 were resuspended
in sorbitol-HEPES buffer (0.6 M sorbitol, 20 mM HEPES-KOH, pH 7.4) con-
taining 50 g/ml aprotinin, 20 g/ml leupeptin, 10 mM 1,10-phenanthroline,
1 mM benzamidine, 50 g/ml trypsin inhibitor, and 50 M phenylmethyl-
sulfonyl fluoride as protease inhibitors. One unit of enzyme activity was
expressed as nanomoles of [14C]HMG-CoA converted to [14C]mevalonate
min1 mg1 protein. Protein was determined by the method of Bradford
(Bradford, 1976).
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Antibody Production and Western Blot Analysis
Polyclonal antiserum against recombinant both TcHMGR and LmHMGR was
generated by immunizing rabbits with the purified protein. Monoclonal
anti-TcHMGR antibodies were obtained as described previously (Coligan et
al., 1995) and purified by affinity chromatography over a protein A-Sepharose
column (Pharmacia) according to the recommendations of the supplier. T.
cruzi and Leishmania cells were ruptured by sonication. Yeast cells were
ruptured using glass beads and the extracts were clarified by centrifugation (5
min, 1500  g). In all cases, 15 g of protein was subjected to electrophoresis
through a 12% SDS-polyacrylamide gel and blotted onto Immobilon-P mem-
branes (Millipore, Bedford, MA) at 25 V for 30 min, by using a SemiDry
Transfer Cell (Bio-Rad). Western analysis of TcHMGR was performed with
monoclonal anti-TcHMGR at 1:5000 dilution by using anti-mouse IgG perox-
idase conjugate (Promega, Madison, WI) as the secondary antibody. Bound
antibody was visualized with the ECL system from Amersham Biosciences.
LmHMGR was analyzed at a 1:25000 dilution of polyclonal anti-LmHMGR by
using anti-rabbit peroxidase conjugate.
Digitonin Permeabilization
Exponential phase T. cruzi cells (6  107 cells/ml) were collected and washed
with phosphate-buffered saline (PBS) and suspended in buffer A (0.25 M
sucrose/10 mM HEPES, pH 7.4/50 mM NaCl/20 mM EDTA/2 mM EGTA/5
mM dithiothreitol) plus protease inhibitors at a concentration of 2  108
cells/ml. The required amount of digitonin was added, and the suspension
was incubated at 28°C for 30 min and centrifuged at 13,000  g for 2 min. The
supernatant was used to assay activity of citrate synthase, pyruvate kinase,
hexokinase, and HMGR as described previously (Cannata and Cazzulo, 1984;
Callens et al., 1991; Pen˜a-Dı´az et al., 1997).
Immunoelectron Microscopy
Yeast cells growing in early exponential phase were harvested by centrifuga-
tion, washed several times with PBS, and fixed with 1% paraformaldehyde
and 1% glutaraldehyde in cacodylate buffer (pH 6.8, 0.05 M). After 4 h at 4°C,
cells were centrifuged and washed three times with cacodylate buffer and
resuspended in 5 ml of 1% sodium metaperiodate. The suspension was
incubated for 15 min at room temperature after which the cells were pelleted
and washed once in distilled water. Subsequent steps of dehydration with
ethanol, infiltration in increasing concentrations of LRWhite resin (ESB) and
embedding were carried out as described previously (Wright and Rine, 1989).
Trypanosomes growing in exponential phase were collected and washed in
PBS. Cells (107) were fixed in Karnowsky solution (1% glutaraldehyde, 4%
paraformaldehyde, 0.05 cacodylate, pH 7.2) at 4°C for 2 h and then washed
with cacodylate, centrifuged, and the pellet dehydrated in progressively
increasing concentrations of ethanol. The sample was embedded in increasing
concentrations of LRWhite and polymerized at 20°C under UV light expo-
sure for 4 d.
Ultrathin sections were treated with NH4Cl for 2 h, incubated 30 min with
3% BSA in PBS (pH 7.4) and 10 min with 0.05% Tween 20, 1% BSA in PBS to
block nonspecific binding sites. Labeling was performed by incubation with
primary monoclonal antibodies raised against recombinant TcHMGR diluted
1:20 and a 1:75 dilution of goat anti-mouse IgG conjugated to 10-nm gold
(Sigma-Aldrich) both diluted with 5% rabbit serum, 0.05% Tween 20, 1% BSA
in PBS. For L. major cells, parasite sections were labeled with purified anti-
LmHMGR antibody (1:80) for 1 h, washed with BSA-PBS solution, and then
goat anti-rabbit IgG coupled with 10-nm gold particles (Sigma-Aldrich) as
secondary antibody. Controls consisted of samples previously incubated with
an excess of recombinant protein or samples without the respective primary
antibody. After staining with uranyl acetate, sections were examined in a
Zeiss 902 electron microscope at 80 kV (Centro deInstrumentacion Cientı´fica,
Universidad deGranada, Granada, Spain). For ultrastructural studies, para-
sites were collected by centrifugation and fixed in a solution containing 2.5%
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, 450 mOsM; washed in
cacodylate buffer; postfixed in 2% osmium tetroxide stained with 2% uranyl
acetate; dehydrated in ethanol; and embedded in Epon.
RESULTS
Construction of Stable Epimastigote Cell Lines
Overexpressing TcHMGR
To investigate the subcellular location of TcHMGR, a cell
line overexpressing the enzyme was obtained. The TCHMGR
gene was obtained by PCR with the plasmid pETHMGR
(Pen˜a-Dı´az et al., 1997) as template DNA and inserted into the
polylinker of the integrative vector pRIBOTEX (Martı´nez-Cal-
villo et al., 1997) by using the BamHI and HindIII cloning sites
so that transcription was under the control of the rDNA pro-
moter. Parasites were transfected with pRIBOTEX-HMGR and
selected with increasing geneticine concentrations up to 2 mg
ml1. Transfectants with this construct exhibited new copies of
the TCHMGR gene located in the rDNA locus as determined
by CHEF and Southern blot analysis. Analysis by RT-PCR
showed that the addition of the splice leader took place at an
AG site in position88 in transfectant cells and in position37
in wild-type cells. Specific activity of TcHMGR in transfectant
cells was 21.5 nmol min1 mg1, threefold higher than that of
wild-type cells. Transfected cells did not show any special
morphological alterations with regard to wild-type cells as
determined by ultrastructural studies.
To determine the location of TcHMGR in T. cruzi cells,
antibodies directed toward epitopes of the recombinant en-
zyme were generated in rabbits. Monoclonals were also
generated and isotyped as Ig G1. In a Western blot analysis,
both types of antibodies recognized a single band in wild-
type parasite lysates that corresponded to a molecular
mass of 46 kDa, similar to that predicted for the translated
TCHMGR coding region. This band was established to be
TcHMGR, and T. cruzi cells overexpressing the enzyme
showed a more intense band of the same size than the
wild type (Figure 1).
TcHMGR in T. cruzi Undergoes Mitochondrial Targeting
An analysis of the amino-terminal sequence of TcHMGR
reveals similarity with proteins described to undergo mito-
chondrial targeting in trypanosomatids. These proteins
carry a short signal (7–9 amino acids) for import to mito-
chondria (Table 1). To determine whether indeed TcHMGR
is located in this compartment, a digitonin titration experi-
ment was performed. Analysis of the proteins obtained at
different detergent concentrations showed that TcHMGR
from wild-type and transfected parasites was poorly recov-
ered at digitonin concentrations 0.5 mg ml1 but coeluted
with the enzyme citrate synthase characteristic from mito-
chondria at higher concentrations. Elution of the mitochon-
drial enzymes occurred at 0.5 mg ml1, glycosomal enzymes
Figure 1. Western blot analysis of the levels of TcHMGR in over-
expressing mutants. Cells were ruptured by sonication and the
extract was clarified by centrifugation (1500  g for 10 min). Lane 1,
supernatant from wild-type T. cruzi; lane 2, supernatant from T.
cruzi cells harboring the vector pRIBOTEX; and lane 3, supernatant
of T. cruzi cells harboring pRIBOTEX-TcHMGR and overexpressing
the TcHMGR protein. All samples were subjected to SDS-PAGE,
transferred to an Immobilon-P membrane, and incubated with a
mAb generated against the recombinant T. cruzi protein.
J. Pen˜a-Diaz et al.
Molecular Biology of the Cell1358
were released from 0.2 to 0.3 mg ml1 digitonin, and elution
was complete at 0.5 mg ml1 (Figure 2). Aliquots obtained
after permeabilization were subjected to Western blot anal-
ysis with polyclonal anti-HMGR, further confirming that
TcHMGR is not released at low detergent concentrations
(our unpublished data).
Immunoelectron microscopy was used to further corrob-
orate mitochondrial targeting of the enzyme, and a mono-
clonal antibody (mAb) was used for this purpose. As shown
in Figure 4A, wild-type epimastigotes showed a small, but
significant number of particles inside the mitochondrion
that can be clearly identified by the presence of the electro-
dense mitochondrial DNA network or kinetoplast. Further-
more, epimastigotes overexpressing HMGR (Figure 3, B–D)
showed a profuse and specific labeling restricted to the
mitochondrial matrix because the number of gold particles
was notably increased relative to wild-type cells. A signifi-
cant number of particles associated to glycosomes or any
other internal organelle could not be evidenced. Likewise,
immunogold labeling indicative of a cytoplasmic milieu was
not apparent either. Particle counting revealed that 90% of
labeling was related to the mitochondrion in T. cruzi cells
overexpressing the enzyme. Although the possibility cannot
be ruled out that HMGR is a minor constituent of other
structures, clearly the major location of the enzyme was
within the matrix of this organelle, and the distribution
pattern was not affected by culture conditions such as in-
creased oxygenation or different culture media (our unpub-
lished data).
Production of Leishmania major Cell Lines
Overexpressing Full-Length and Truncated Forms of
LmHMGR
The amino terminus of LmHMGR, similar to T. cruzi, also
contains a putative mitochondrial targeting sequence (Table
1). To determine the intracellular location of HMGR in other
members of the Trypanosomatidae family and the impor-
tance of this sequence in mitochondria internalization, we
have generated a L. major cell line overexpressing full-length
and two truncated versions of LmHMGR, HMGR1 and
HMGR2, that lack the first 14 and 19 amino acids of the
amino terminal region, respectively. For HMGR1, a methi-
onine was introduced in the amino terminus for correct
translation, whereas for HMGR2, advantage was taken of a
preexisting methionine in position 20. The resulting trans-
fectants were analyzed by Western blot for overproduction
of HMGR, and enzyme activity was quantified. As shown in
Figure 4, cells overexpressing HMGR present approximately
a ninefold increase in protein when assessed by Western
blot, whereas in cells overproducing HMGR1 and HMGR2
bands of a slightly lower molecular mass seemed to be
increased approximately fivefold, as revealed by densito-
metric analysis with regard to wild-type cells. Likewise,
when enzyme activity values were measured in extracts,
cells overproducing HMGR and HMGR2 rendered in-
creased specific activities of approximately nine- and five-
fold, respectively, with regard to controls.
Mitochondrial Targeting Is Impaired in Mutants
Expressing Truncated Forms of LmHMGR
We have assessed if in Leishmania HMGR is also situated in
the mitochondrion and furthermore if mitochondrial inter-
nalization is impaired in mutants overexpressing modified
versions of LmHMGR were the targeting sequence has been
eliminated. Immunoelectron microscopy was also accom-
plished for this purpose by using a rabbit polyclonal anti-
body raised against homogeneous purified recombinant
protein. Photographs of thin sections of cells overexpressing
full-length HMGR as well as wild-type cells are shown in
Figure 5. Again, in the trypanosomatide L. major, the enzyme
was clearly located in the mitochondrial matrix. Profuse
labeling was observed in overexpressing cells (Figure 5, B
Table 1. Comparison of the amino-terminal sequence of TcHMGR and LmHMGR with those of different trypanosomatid proteins that
undergo mitochondrial import
Organism Amino terminal sequencea Protein
T. cruzi MFRRAILLGCSAAK HMGR
L. major (Montalvetti et al., 2000) MRRSLLLACSAAKGESWASM HMGR
T. brucei (Else et al., 1994) MFRRCFPIF*NPYD Lipoamide dehydrogenase
C. fasciculata (Xu and Ray, 1993) MLRRSPTLL*RVSP p17
T. cruzi (Giambiagi de Marval et al., 1993) MFRSAARF*AGKE hsp60
L. tarentolae (Bringaud et al., 1995) MLRATLAR*EMAP p51, aldehyde dehydrogenase
L. tarentolae (Bringaud et al., 1995) MRRLSSQLMCTAAAVRF*ASAG p18
L. major (Searle et al., 1993) MFARRVCGTAAASAACLVRC*ASDK mhsp70
a Positively charged residues are in bold. Sequence homologies are underlined.
* Denotes known cleavage sites.
Figure 2. Digitonin titration of TcHMGR. Activities of
pyruvate kinase (open triangles), hexokinase (open squares),
citrate synthase (open circles), and 3-hydroxy-3-methyl-glu-
taryl-CoA reductase (closed circles) in supernatants of whole
T. cruzi suspensions in solutions of increasing digitonin con-
centrations. Enzyme total activity is expressed as a percent-
age, taking as 100% the total activity obtained in supernatants
after permeabilization with 0.5% Triton X-100. (A) Activities
recovered from T. cruzi wild-type supernatants. (B) Activities
recovered in supernatants of T. cruzi parasites transfected
with pRIBOTEX-TcHMGR and overexpressing HMGR.
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and C), indicating that the intact enzyme, when overpro-
duced, is efficiently transported across the mitochondrial
membrane. However in mutants were the amino terminal
sequence has been perturbed (Figure 6, A–C), HMGR seems
to accumulate in the cytosol, and an intense labeling of the
mitochondrial matrix is no longer evident. The small num-
ber of gold particles within the mitochondrion would cor-
respond to the full-length enzyme encoded by the chromo-
somal gene copy, whereas the transgene-encoded enzyme is
retained in the cytoplasm.
Expression of T. cruzi 3-Hydroxy-3-methylglutaryl-CoA
Reductase Supports Growth of hmg1 hmg2 S. cerevisiae
Mutant Cells
Considering the sequence similarity between HMGR from T.
cruzi and the soluble domain of S. cerevisiae reductase, we
tested whether expression of the parasite enzyme could
rescue the growth defect of a hmg1 hmg2 yeast double mu-
tant. This mutant lacks both HMGR isozymes and cannot
grow in the absence of mevalonate, the product of the reac-
tion catalyzed by HMGR. Plasmid pAN10HMGTc, in which
the ADH1 promoter drives the expression of the TcHMGR
coding sequence from T. cruzi, complemented the pheno-
type of the double mutant and allowed it to grow in the
absence of mevalonate. Extracts from wild type and the
transformed double hmg1 hmg2 mutant were analyzed for
expression of the HMGR protein by SDS-PAGE. Although a
46-kDa band corresponding to the T. cruzi enzyme was not
evident in transformed cells, Western blot analysis with a
specific mAb for T. cruzi HMGR that had no cross-reaction
with the yeast enzymes revealed a specific band in the
Figure 4. Western blot analysis of the levels of LmHMGR in over-
expressing mutants. Cells were ruptured by sonication and the
extract was clarified by centrifugation (1500  g for 10 min). Lane 1,
supernatant from wild-type L. major; lane 2, supernatant of L. major
cells harboring pSP72hmgr and overexpressing LmHMGR; lane 3,
supernatant of L. major cells harboring pSP72hmgr1; and lane 4,
supernatant of L. major cells harboring the pSP72hmgr2. All samples
were subjected to SDS-PAGE, transferred to an Immobilon-P mem-
brane, and incubated with a polyclonal antibody generated against
recombinant LmHMGR.
Figure 3. Immunoelectron microscopy localization of HMGR to
the mitochondrion. T. cruzi epimastigotes were fixed in 4% parafor-
maldehyde and 0.1% glutaraldehyde and embedded in LRWhite
resin. Thin sections were immunolabeled with anti-TcHMGR mono-
clonal antibodies followed by goat anti-mouse immunoglobulin
conjugated to gold (10-nm probe). Magnification is 40,000. (A)
Section of wild-type T. cruzi epimastigotes showing gold labeling of
the mitochondrial matrix. No label is present in glycosomes or the
cytosol. (B–D) Longitudinal sections of T. cruzi epimastigote cells
transfected with the expression vector pRIBOTEX-TcHMGR show-
ing intense gold labeling of the mitochondrial matrix. G, glycosome;
K, kinetoplast; M, mitochondrion.
Figure 5. Immunoelectron microscopy localization of HMGR in
wild-type and mutant cells overexpressing full-length HMGR. L.
major promastigotes were fixed in 4% paraformaldehyde and 0.1%
glutaraldehyde and embedded in LRWhite resin. Thin sections were
immunolabeled with anti-LmHMGR (dilution 1:70) polyclonal an-
tibodies followed by goat anti-rabbit immunoglobulin conjugated to
gold (10-nm probe). Magnification is 31,500 in A and B and
16,000 in C. (A) Section of wild-type L. major promastigotes show-
ing gold labeling of the mitochondrial matrix. (B and C) Longitudi-
nal sections of L. major promastigote cells transfected with the
expression vector pSP72hmgr showing intense gold labeling of the
mitochondrial matrix. G, glycosome; K, kinetoplast; M, mitochon-
drion.
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transformants (our unpublished data). Moreover, the spe-
cific activity of HMGR in the yeast transformants was one
order of magnitude higher than that in wild-type type cells
grown under the same conditions (5.08 and 0.48 nmol min1
mg1, respectively). All these results clearly demonstrate
that the T. cruzi enzyme is functional in yeast.
To assess the intracellular location of the overexpressed
TcHMGR in S. cerevisiae, cells were analyzed by immuno-
electron microscopy. Thin sections corresponding to the
wild-type S. cerevisiae strain W303 and the S. cerevisiae strain
CFL9 were labeled with anti-TcHMGR monoclonal antibod-
ies (Figure 7). Gold particles were mainly observed within
the mitochondrion and concentrated in the membrane re-
gion, although a certain amount of labeling remained asso-
ciated to the outer mitochondrial membrane. Cells not over-
expressing the protein did not show any significant labeling.
DISCUSSION
The indication of a atypical subcellular location for HMGR
from T. cruzi came from the isolation of the gene and char-
acterization of the recombinant protein (Pen˜a-Dı´az et al.,
1997). An outstanding feature was the lack of the amino-
terminal membrane binding domain characteristic of the
other eukaryotic proteins reported to date. The enzyme was
shown to exist in a soluble form constituting the sole exam-
ple of a soluble HMGR in eukaryotes. The enzyme from L.
major was also characterized and defined as a soluble protein
(Montalvetti et al., 2000). In addition, the T. brucei gene for
HMGR is currently available in the database and also lacks
sequences coding for a membrane spanning domain.
In Eukaryotae, the initial steps of cholesterol biosynthesis
probably occur mainly in the cytosol, and the later steps in
the ER. However, several enzymes of the cholesterol biosyn-
thetic pathway have also been reported to exist in peroxi-
somes (Olivier and Krisans, 2000). For example although the
majority of HMGR resides in the ER, significant peroxisomal
activity has also been detected in rat liver (Keller et al., 1986).
In trypanosomatids, the localization of this enzyme has been
subjected to controversy; thus, it has been reported to be
microsomal in T. cruzi (Concepcio´n et al., 1998) and micro-
somal and mitochondrial in T. brucei (Coppens et al., 1995;
Heise and Opperdoes, 2000). In both cases, localization anal-
ysis was performed by cell fractionation and digitonin titra-
tion. Difficulties in the use of other conventional techniques
arise from the lack of characterized enzymes from these
sources and the special morphology of the mitochondria in
these parasites, although protocols to isolate sealed and
tRNA import competent mitochondria are available (Hauser
et al., 1996). The mitochondrion in trypanosomatids is
unique. There is a single mitochondrion per cell, and it
extends throughout in a complex branched structure (Clay-
ton et al., 1995; De Souza, 1999).
Overexpressing mutants were used in this study due to
very low levels of HMGR in wild-type cells. The moderate
levels of overexpression obtained did not occasion any ap-
parent physiological changes in the cell. Thus, modifications
in membrane proliferation such as those reported for yeast
cells overexpressing HMGR were not found in overexpress-
ing T. cruzi cells (Wright and Rine, 1989). In yeast HMGR,
sequences involved in the formation of these membrane
arrays have been found in one of the lumenal loops between
transmembrane domains, which is absent in TcHMGR (Parrish
et al., 1995). For Leishmania, LmHMGR was expressed from a
transgene located in the episomal vector pSP72NEO devel-
oped by Papadopoulou et al. (1994), and again no profound
morphological alterations seemed to occur in overexpressing
mutants with regard to wild-type cells.
Monoclonal antibodies raised against the recombinant en-
zyme were tested in immunoelectron microscopy studies
after their specificity was established. Results showed a
distinct and specific mitochondrial matrix labeling in T. cruzi
Figure 6. Immunoelectron microscopy localization of HMGR in L.
major promastigotes overexpressing HMGR1 and HMGR2. Cells
were fixed in 4% paraformaldehyde and 0.1% glutaraldehyde and
embedded in LRWhite resin. Thin sections were immunolabeled
with anti-LmHMGR (dilution 1:70) polyclonal antibodies followed
by goat anti-rabbit immunoglobulin conjugated to gold (10-nm
probe). Magnification is 25,000 in A and C and 31,500 in B. (A)
Section of L. major promastigotes transfected with the expression
vector pSP72hmgr1 expressing a form of HMGR that lacks the first
14 amino acids. (B and C) Longitudinal sections of L. major promas-
tigote cells transfected with the expression vector pSP72hmgr2 ex-
pressing a form of HMGR that lacks the first 19 amino acids.
Increased gold labeling of the cytoplasm is evidenced. G, glyco-
some; K, kinetoplast; M, mitochondrion.
Figure 7. Transmission electron micrographs of ultrathin section
of yeast cells embedded in LRWhite resin and immunolabeled with
anti-HMGR monoclonal antibodies. Cells were fixed in 1% parafor-
maldehyde and 1% glutaraldehyde and immunolabeled with anti-
HMGR monoclonal antibodies followed by goat anti-mouse immu-
noglobulin conjugated to gold (10-nm probe). (A) S. cerevisiae W303
cells. (B) S. cerevisiae CFL9 cells. Magnification is 31,500 in A and
50,000 in B. N, nucleus; M, mitochondrion.
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epimastigotes, whereas no significant labeling occurred in
other cell compartments. Similar observations were obtained
in Leishmania promastigote cells. The present results provide
the first clear-cut demonstration of the mitochondrial loca-
tion of an enzyme involved in isoprenoid biosynthesis in the
Trypanosomatidae family by using both biochemical and
immunological techniques. It has been argued that differen-
tial metabolic conditions may be responsible for the differ-
ences found in sensitivity to digitonin (Rodrigues et al.,
2001). However, we have failed to obtain a different distri-
bution pattern for the enzyme under different growth con-
ditions (i.e., increased oxygenation).
T. cruzi HMGR in yeast cells devoid of the genes coding
for the two HMGR isoenzymes was found to overcome the
auxotrophy for mevalonate, indicating functional conserva-
tion of enzyme activity. Levels of activity found in trans-
fected yeast cells were increased 1 order of magnitude with
respect to the wild-type cells; thus, a correct translation and
folding seems to occur. A hydrophobic domain found in the
sequence in position 96–112 may account for a weak matrix
stop-transfer signal responsible for the arrest of the protein
in the mitochondria and or the intermembrane space (Ho-
vius, 1998). On the other hand, the small amount of enzyme
that remained unimported in the cytosolic compartment
may have contributed toward the maintenance of viability in
the absence of endogenous yeast reductase.
The reason for the mitochondrial compartimentalization
of TcHMGR in T. cruzi remains unclear, because the enzyme
is ER attached in mammalian cell systems. Recent results
point out toward a possible metabolic role of a HMGR in
mitochondria correlating leucine degradation and sterol bio-
synthesis. The majority of T. brucei HMGR activity (Heise
and Opperdoes, 2000) has been also found associated to
mitochondria. This may represent a common feature of
trypanosomatids and raises the question on the origin of the
necessary precursors for HMGR activity inside the mito-
chondrion. Reports by Ginger et al. (1999, 2000, 2001) have
shown that trypanosomatids rely to different extents on the
degradation of leucine as a carbon source for isoprenoid.
This process, in parallel with mammalian cells, takes place in
the mitochondrial matrix. Although incorporation of carbon
from a leucine source in T. cruzi seems to be considerable
less significant than the amount seen with Leishmania and
Endotrypanum species (Ginger et al., 2001), it is uncertain to
what extent results obtained in the related work are affected
by the contribution of unlabeled leucine from exogenous or
endogenous protein. The compartimentalization of the en-
zymes involved in the degradation of leucine and first steps
of the mevalonate pathway would confer considerable ad-
vantages in energy economy for these organisms. The local-
ization of HMG-CoA synthase has not been yet established
in trypanosomatids, but in mammals, this enzyme has been
described to have a dual localization, both cytosolic and
mitochondrial (Royo et al., 1993), with the latter being in-
volved in ketogenesis.
In summary, the present study clarifies the controversy
raised around the localization of this enzyme in trypanoso-
matids. Work is in progress to characterize other enzymes of
the mevalonate pathway and to determine the extent of
mitochondria-associated isoprenoid biosynthesis in these or-
ganisms.
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